More articles from Chronic Kidney Disease

You have accessRestricted Access
Family Consultation to Reduce Early Hospital Readmissions among Patients with End Stage Kidney Disease
Matthew J. Jasinski, Mark A. Lumley, Sandeep Soman, Jerry Yee and Mark W. Ketterer

CJASN June 2018, 13 (6) 850-857; DOI: https://doi.org/10.2215/CJN.08450817

Add to Selected Citations
You have accessRestricted Access
Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis
Chia-Lin Wu, Chia-Chu Chang, Chew-Teng Kor, Tao-Hsiang Yang, Ping-Fang Chiu, Der-Cherng Tarng and Chih-Cheng Hsu

CJASN May 2018, 13 (5) 702-709; DOI: https://doi.org/10.2215/CJN.11781017

Add to Selected Citations
You have accessRestricted Access
Time-Centered Approach to Understanding Risk Factors for the Progression of CKD
Elaine Ku, Kirsten L. Johansen and Charles E. McCulloch

CJASN May 2018, 13 (5) 693-701; DOI: https://doi.org/10.2215/CJN.10360917

Add to Selected Citations
You have accessRestricted Access
Black Americans’ Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease
Ebele M. Umeukeje, Marcus G. Wild, Saugar Maripuri, Teresa Davidson, Margaret Rutherford, Khaled Abdel-Kader, Julia Lewis, Consuelo H. Wilkins and Kerri Cavanaugh

CJASN April 2018, 13 (4) 551-559; DOI: https://doi.org/10.2215/CJN.07580717

Add to Selected Citations
You have accessRestricted Access
Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease
Sarah Seiler-Mussler, Anne S. Limbach, Insa E. Emrich, John W. Pickering, Heinz J. Roth, Danilo Fliser and Gunnar H. Heine

CJASN April 2018, 13 (4) 569-576; DOI: https://doi.org/10.2215/CJN.06620617

Add to Selected Citations
You have accessRestricted Access
Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate
Feijie Wang, Liang Sun, Qi Sun, Liming Liang, Xianfu Gao, Rongxia Li, An Pan, Huaixing Li, Yueyi Deng, Frank B. Hu, Jiarui Wu, Rong Zeng and Xu Lin

CJASN April 2018, 13 (4) 560-568; DOI: https://doi.org/10.2215/CJN.07650717

Add to Selected Citations
You have accessRestricted Access
Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients
Milica Bozic, Angels Betriu, Marcelino Bermudez-Lopez, Alberto Ortiz, Elvira Fernandez, Jose M. Valdivielso and on behalf of the NEFRONA investigators

CJASN April 2018, 13 (4) 577-584; DOI: https://doi.org/10.2215/CJN.07980717

Add to Selected Citations
You have accessRestricted Access
Person-Centered Integrated Care for Chronic Kidney Disease
Pim P. Valentijn, Fernando Abdalla Pereira, Marinella Ruospo, Suetonia C. Palmer, Jörgen Hegbrant, Christina W. Sterner, Hubertus J.M. Vrijhoef, Dirk Ruwaard and Giovanni F.M. Strippoli

CJASN March 2018, 13 (3) 375-386; DOI: https://doi.org/10.2215/CJN.09960917

Add to Selected Citations
You have accessRestricted Access
Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans
Joseph Lunyera, Clemontina A. Davenport, Nrupen A. Bhavsar, Mario Sims, Julia Scialla, Jane Pendergast, Rasheeda Hall, Crystal C. Tyson, Jennifer St. Clair Russell, Wei Wang, Adolfo Correa, L. Ebony Boulware and Clarissa J. Diamantidis

CJASN February 2018, 13 (2) 213-222; DOI: https://doi.org/10.2215/CJN.06430617

Add to Selected Citations
You have accessRestricted Access
Association between Urine Ammonium and Urine TGF-β1 in CKD
Kalani L. Raphael, Sarah Gilligan, Thomas H. Hostetter, Tom Greene and Srinivasan Beddhu

CJASN February 2018, 13 (2) 223-230; DOI: https://doi.org/10.2215/CJN.07510717

Add to Selected Citations

Main menu

User menu

Search

More articles from Chronic Kidney Disease

Pages

About

Author Information

More information